Oxygen

Oxygen therapy is used in COPD patients with chronic hypoxemia (low blood oxygen levels), typically when oxygen saturation is ≤88% at rest. Long-term oxygen therapy (LTOT) has been shown to improve survival, exercise tolerance, and quality of life in these individuals. It is usually prescribed for patients with advanced COPD, especially those with resting hypoxemia or significant desaturation during sleep or exertion. Oxygen can be delivered via portable tanks or concentrators and may be used continuously or during specific activities. It’s important to monitor oxygen levels regularly to ensure appropriate use and avoid complications like carbon dioxide retention in certain patients.

Treatment Type: Prescription Medication

Treatment Class: N/A

Treatment Modality: N/A

Oxygen

Review Summary

4.0

1 Reviews

Preferred by 1 Reviewers

Based on the review, oxygen therapy is highly effective for COPD patients with severe hypoxemia (SpO2 ≤88%), as it improves survival and quality of life. However, for patients with moderate hypoxemia, there is no clear long-term mortality benefit, though short-term use during acute illness can provide symptomatic relief.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost
3.0
1 = Very Expensive 5 = Very Affordable

3.0

Moderate Cost
Relief Speed
5.0
1 = No Relief 5 = Immediate Relief

5.0

Immediate Relief
Side Effects
5.0
1 = Intolerable Effect 5 = No Effect

5.0

No Effect
Treatment Line
1.0
1 = Third-line or more 5 = First-line

1.0

Third-line or more

Explore various treatment options to empower yourself in making a well-informed choice.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

4.0

1 Reviews
5
0%
4
100%
3
0%
2
0%
1
0%

AI Summary of User Experiences

Not medical advice.

Based on the review, oxygen therapy is highly effective for COPD patients with severe hypoxemia (SpO2 ≤88%), as it improves survival and quality of life. However, for patients with moderate hypoxemia, there is no clear long-term mortality benefit, though short-term use during acute illness can provide symptomatic relief.

Reviews

Filter by reviewer type Pro

Select all Clear all

Cost
Very Expensive
$1000+
Expensive
$501 to $1000
Moderate Cost
$101 to $500
Affordable
$25 to $100
Very Affordable
$25
Relief Speed
No Relief
No noticeable improvement
Slow Relief
Several days to weeks
Moderate Relief
Within 1 - 3 days
Fast Relief
Within hours
Immediate Relief
Within minutes
Side Effect
Intolerable Side Effect
Caused treatment to stop or required hospitalization
Severe Side Effect
Difficult to tolerate, may require intervention
Moderate Side Effect
Noticeable, but manageable
Mild Side Effect
Minor, not bothersome
No Side Effect
Without any adverse effects
Treatment Line
Third-line or more
Used after second-line failed or multiple prior treatment
Second-line
Used after first-line treatment failed or was unsuitable
First-line
First treatment tried
Dr. Curbside

Dr. Curbside

Verified
Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add
2 months ago
Oxygen can be used for severe COPD when oxygen levels are chronically low. It helps improve oxygenation and can reduce strain on the heart and other organs. Because it’s a more intensive therapy, it’s generally reserved for patients with significant hypoxemia, rather than mild or moderate COPD.
#ModerateCost #ImmediateRelief #NoEffect #Third-lineOrMore #Maintenance
View Professional Disclosures

Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.

We use cookies to personalize our services and provide you with the best possible experience. By continuing to use this site, you agree to this cookie usage. We also use third-party cookies that help us analyse how you use this website, store your preferences, and provide the content and advertisements that are relevant to you. These cookies will only be stored in your browser with your prior consent. You can learn more about cookies and how your data is processed in the Privacy Policy.

Strictly Necessary Only Accept All